Jaypirca Interactions
There are 736 drugs known to interact with Jaypirca (pirtobrutinib), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 106 are major, 609 are moderate, and 21 are minor.
- View all 736 medications that may interact with Jaypirca
- View Jaypirca alcohol/food interactions (1)
- View Jaypirca disease interactions (2)
Most frequently checked interactions
View interaction reports for Jaypirca (pirtobrutinib) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- acetaminophen / butalbital / caffeine
- acetaminophen / hydrocodone
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- acyclovir
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Afrin (oxymetazoline nasal)
- Andembry (garadacimab)
- Aubagio (teriflunomide)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- fluoxetine
- furosemide
- Gazyva (obinutuzumab)
- Gemtesa (vibegron)
- Imbruvica (ibrutinib)
- ketorolac
- losartan
- omeprazole
- Rituxan (rituximab)
- saw palmetto
- simvastatin
- Tecfidera (dimethyl fumarate)
Jaypirca alcohol/food interactions
There is 1 alcohol/food interaction with Jaypirca (pirtobrutinib).
Jaypirca disease interactions
There are 2 disease interactions with Jaypirca (pirtobrutinib) which include:
Report options
QR code containing a link to this page
More about Jaypirca (pirtobrutinib)
- Jaypirca consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
